Physician

David Ashir Jawahar, MD

According to 2025 Medicare claims, David Jawahar, MD (NPI: 1306828330) practices pulmonary disease in the Dover, DE market, with the plurality of this provider's patient population coming from Kent, DE. This provider's primary affiliated billing organization is KENT PULMONARY ASSOCIATES (NPI: 1801801675; TIN: 20-4103654) and primary practice location at 19904-4137. Jawahar is affiliated with the UM ACO (ACO ID: A2754), participating under the MSSP model.

Jawahar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,602 traditional Medicare patients, billed 19,459 HCPCS/CPT codes, and received $839,915 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,531 prescription claims across 742 beneficiaries totaling $2,421,506 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 5,909 claims. Open Payments data shows 77 records totaling $1,659. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $387,078 to $839,915. Similarly, Part D prescription costs have risen steadily, from $747,824 to $2,421,506. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $436,248 and ending at $310,616.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,449	7,699	$387,078
2016	1,389	7,171	$360,059
2017	2,063	10,009	$522,363
2018	1,812	8,067	$408,303
2019	1,823	9,992	$445,768
2020	1,898	9,045	$454,382
2021	2,112	9,107	$502,575
2022	2,683	12,365	$671,675
2023	2,740	15,582	$799,164
2024	2,602	19,459	$839,915

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	435	2,274	$747,824
2016	427	2,368	$916,895
2017	435	2,267	$1,096,993
2018	437	1,944	$1,086,131
2019	428	1,863	$885,176
2020	462	2,296	$1,311,894
2021	422	1,851	$1,261,809
2022	549	2,180	$1,346,778
2023	607	2,828	$1,772,211
2024	742	3,531	$2,421,506

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,293	7,007	$472,511
2016	2,321	6,990	$308,284
2017	2,313	6,808	$220,891
2018	1,932	5,339	$193,964
2019	1,342	3,453	$111,678
2020	1,241	2,877	$114,902
2021	1,415	3,723	$201,318
2022	1,519	4,693	$288,999
2023	1,718	5,789	$374,387
2024	1,803	5,909	$308,737

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	2,373	5,219	$92
94729	Test to examine how well the lungs exchange gases	1,448	1,484	$42
94726	Test to determine lung volumes using sensors	1,446	1,484	$42
94060	Test to measure expiratory airflow and volume changes before and after medication administration	1,445	1,482	$29
94664	Evaluation of use of breathing device	1,446	1,482	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	830	50,325	$1,032,304
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	182	9,480	$192,841
Fasenra Pen	Benralizumab	23	1,176	$131,621
Dupixent Pen	Dupilumab	34	897	$124,721
Ambrisentan	Ambrisentan	19	750	$116,829

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	152	1,165	$84,970
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	57	$57,736
A7030	Full face mask used with positive airway pressure device, each	N	111	274	$21,729
A7031	Face mask interface, replacement for full face mask, each	N	103	261	$21,695
A7032	Cushion for use on nasal mask interface, replacement only, each	N	78	193	$19,950

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	77	$1,659	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Ashir Jawahar, MD?

Tedicare shows public-source Medicare data for David Ashir Jawahar, MD (NPI 1306828330), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Ashir Jawahar, MD have ACO affiliation data?

David Ashir Jawahar, MD is shown with ACO affiliation data for UM ACO (MSSP, ACO ID A2754).

What billing organization is linked to David Ashir Jawahar, MD?

David Ashir Jawahar, MD is linked to KENT PULMONARY ASSOCIATES (billing NPI 1801801675) in the available physician profile data.

Does David Ashir Jawahar, MD have Open Payments data?

David Ashir Jawahar, MD has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.